Z-2673-2014 Class II Terminated
FDA device recall Z-2673-2014 was initiated by Becton Dickinson & Company on Jul 22, 2014 and is designated Class II. Reason for recall: BD received some reports of open seals found on the BD Posiflush SF Flush Syringe 10 mL (Ref #306553). The recall status is terminated (terminated Apr 21, 2015). Affected quantity: 3,088,320 units.
Recall details
- Product Type
- Devices
- Report Date
- Oct 1, 2014
- Initiation Date
- Jul 22, 2014
- Termination Date
- Apr 21, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,088,320 units
Product description
BD PosiFlush SF Saline Flush Syringe 0.9 Sodium Chloride Injection, USP 10 mL REF 306553. Intended to be used only for the flushing of indwelling vascular access devices.10 mL BD PosiFlush Normal Saline Flush Syringes are generally compatible for use with syringe pumps.
Reason for recall
BD received some reports of open seals found on the BD Posiflush SF Flush Syringe 10 mL (Ref #306553).
Distribution pattern
Nationwide Distribution.
Code information
REF #306553 Lot numbers 3024261 - exp 12-2015 3046276 - exp 01-2016 4128353 - exp 04-2017
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2673-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026